Zhengye Biotechnology Holding Limited
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | +21.6% | -18.7% | -12.0% | -37.6% | |
| – | +20.4% | -23.4% | +16.2% | -2.7% | |
| – | +22.4% | -15.4% | -29.7% | -73.9% | |
| – | +18.1% | -11.3% | +7.5% | +40.8% | |
| – | +30.1% | -10.7% | +146.6% | -51.4% | |
| – | +20.1% | -3.2% | +99.3% | -45.5% | |
| – | +25.7% | -31.7% | -61.8% | -497.5% | |
| – | +171.4% | +55.8% | -8.6% | -15.9% | |
| – | +20.4% | -31.5% | -67.1% | -599.3% | |
| – | +23.8% | -23.5% | – | – | |
| – | +20.0% | -32.7% | -64.0% | -717.0% | |
| – | +22.0% | -15.7% | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.